Mauna Kea Technologies SA (EPA:ALMKT)
France
· Delayed Price · Currency is EUR 0.173
0.00 (-0.23%)
Feb 20, 2025, 4:35 PM CET
Mauna Kea Technologies Company Description
Mauna Kea Technologies SA, a medical device company, manufactures and sells medical devices in Europe and internationally.
It offers range of medical devices in gastroenterology, pulmonology, and urology areas. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform which enables physicians to monitor progression of disease over time, assess point-in-time reactions, classify indeterminate areas, and guide surgical interventions.
The company was incorporated in 2000 and is headquartered in Paris, France.
Mauna Kea Technologies SA
| Country | France |
| Founded | 2000 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 68 |
| CEO | Alexandre Loiseau |
Contact Details
Address: 9, rue d'Enghien Paris, 75010 France | |
| Phone | 33 1 48 24 03 45 |
| Website | maunakeatech.com |
Stock Details
| Ticker Symbol | ALMKT |
| Exchange | Euronext Paris |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | FR0010609263 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Alexandre Loiseau Ph.D. | Co-Founder, Chief Executive Officer and Chairman |
| Come de La Tour du Pin | Chief Financial Officer |
| Nathalie Lecoq | Chief Operating Officer |
| Frederic Banegas Ph.D. | Chief Technology Officer |
| François Lacombe Ph.D. | Chief Scientific Officer |
| Daryl Donatelli | Vice President of Global Marketing and U.S. Sales |